{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:14:28Z","timestamp":1774332868271,"version":"3.50.1"},"reference-count":65,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.14.04057","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:33:52Z","timestamp":1710491632000},"source":"Crossref","is-referenced-by-count":6,"title":["Association between 19 medication use and risk of common cancers: A cross-sectional and Mendelian randomisation study"],"prefix":"10.7189","volume":"14","author":[{"given":"Zhangjun","family":"Yun","sequence":"first","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"First School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"First School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaodan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiah Shean","family":"Teo","sequence":"additional","affiliation":[{"name":"School of Traditional and Complementary Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"First School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"First School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4223","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"key-10.7189\/jogh.14.04057-202403150922-R1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jash.2016.08.006","article-title":"Worldwide prevalence of hypertension exceeds 1.3 billion.","volume":"10","author":"Bloch","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.","volume":"12","author":"Bangalore","year":"2011","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R5","doi-asserted-by":"publisher","first-page":"E1073","DOI":"10.1503\/cmaj.101497","article-title":"Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.","volume":"183","author":"Yoon","year":"2011","journal-title":"CMAJ"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1016-8478(23)13226-2","article-title":"Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.","volume":"20","author":"Yang","year":"2005","journal-title":"Mol Cells"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0167-4889(97)00129-8","article-title":"Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells.","volume":"1401","author":"Chua","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/01.RES.68.2.450","article-title":"Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.","volume":"68","author":"Daemen","year":"1991","journal-title":"Circ Res"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R10","doi-asserted-by":"publisher","first-page":"H1043","DOI":"10.1152\/ajpheart.01018.2010","article-title":"Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.","volume":"301","author":"Buharalioglu","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R11","doi-asserted-by":"publisher","first-page":"67150","DOI":"10.18632\/oncotarget.11567","article-title":"Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R12","first-page":"1139","article-title":"Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.","volume":"2","author":"Uemura","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.euroneuro.2015.04.010","article-title":"Anti-depressant therapy and cancer risk: a nested case-control study.","volume":"25","author":"Boursi","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.pcan.4501003","article-title":"Antidepressants and risk of prostate cancer: a nested case-control study.","volume":"11","author":"Tamim","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jad.2017.11.039","article-title":"Prostate cancer and antidepressants: A nationwide population-based nested case-control study.","volume":"227","author":"Lin","year":"2018","journal-title":"J Affect Disord"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3945\/an.115.009258","article-title":"Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy.","volume":"7","author":"Ahluwalia","year":"2016","journal-title":"Adv Nutr"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41467-019-09572-5","article-title":"Genome-wide association study of medication-use and associated disease in the UK Biobank.","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10238-020-00622-7","article-title":"Cross-sectional associations between angiotensin-converting enzyme inhibitor use and cancer diagnosis in US adults.","volume":"20","author":"Smith","year":"2020","journal-title":"Clin Exp Med"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jamainternmed.2019.6019","article-title":"Association Between Exposure to Pyrethroid Insecticides and Risk of All-Cause and Cause-Specific Mortality in the General US Adult Population.","volume":"180","author":"Bao","year":"2020","journal-title":"JAMA Intern Med"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting.","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R24","doi-asserted-by":"publisher","first-page":"e012177","DOI":"10.1136\/bmjopen-2016-012177","article-title":"Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.","volume":"6","author":"Nevado-Holgado","year":"2016","journal-title":"BMJ Open"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets.","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci.","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ng.3002","article-title":"Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","article-title":"Discovery of common and rare genetic risk variants for colorectal cancer.","volume":"51","author":"Huyghe","year":"2019","journal-title":"Nat Genet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat Genet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nmeth.1974","article-title":"The 1000 Genomes Project: data management and community access.","volume":"9","author":"Clarke","year":"2012","journal-title":"Nat Methods"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R31","doi-asserted-by":"publisher","first-page":"13784","DOI":"10.1002\/cam4.6022","article-title":"Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.","volume":"12","author":"Yun","year":"2023","journal-title":"Cancer Med"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/ije\/dyz200","article-title":"Education protects against coronary heart disease and stroke independently of cognitive function: evidence from Mendelian randomization.","volume":"48","author":"Gill","year":"2019","journal-title":"Int J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R33","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1093\/ije\/dyy265","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators.","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R36","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/genetics\/163.3.1153","article-title":"Maximum-likelihood estimation of relatedness.","volume":"163","author":"Milligan","year":"2003","journal-title":"Genetics"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.12688\/wellcomeopenres.19995.2","article-title":"MendelianRandomization v0.9.0: updates to an R package for performing Mendelian randomization analyses using summarized data.","volume":"8","author":"Patel","year":"2023","journal-title":"Wellcome Open Res"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R38","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1214\/19-AOS1866","article-title":"Statistical Inference in Two-Sample Summary-Data Mendelian Randomization Using Robust Adjusted Profile Score.","volume":"48","author":"Zhao","year":"2020","journal-title":"Ann Stat"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","article-title":"Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy.","volume":"68","author":"Cohen","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R42","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/s41588-018-0255-0","article-title":"Distinguishing genetic correlation from causation across 52 diseases and complex traits.","volume":"50","author":"O\u2019Connor","year":"2018","journal-title":"Nat Genet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","article-title":"LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1470-2045(10)70271-0","article-title":"Blood-pressure drugs and cancer: much ado about nothing?","volume":"12","author":"Lindholm","year":"2011","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1470-2045(10)70159-5","article-title":"Angiotensin-receptor blockade, cancer, and concerns.","volume":"11","author":"Julius","year":"2010","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R47","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/pros.20407","article-title":"Renin-angiotensin system is an important factor in hormone refractory prostate cancer.","volume":"66","author":"Uemura","year":"2006","journal-title":"Prostate"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/02841860310022346","article-title":"Angiotensin converting enzyme inhibitors for cancer treatment?","volume":"43","author":"Lindberg","year":"2004","journal-title":"Acta Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R49","doi-asserted-by":"publisher","first-page":"1470320316656679","DOI":"10.1177\/1470320316656679","article-title":"Renin-angiotensin system blockade for the risk of cancer and death.","volume":"17","author":"Shen","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pros.10160","article-title":"Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells.","volume":"54","author":"Lin","year":"2003","journal-title":"Prostate"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/pros.21049","article-title":"Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.","volume":"70","author":"Kosaka","year":"2010","journal-title":"Prostate"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1677\/JME-07-0094","article-title":"Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells.","volume":"39","author":"Nogueira","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.59.2.3","article-title":"Nonclassic endogenous novel [corrected] regulators of angiogenesis.","volume":"59","author":"Ribatti","year":"2007","journal-title":"Pharmacol Rev"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R54","doi-asserted-by":"publisher","first-page":"134S","DOI":"10.1016\/j.amjhyper.2005.05.005","article-title":"How to explain the differences between renin angiotensin system modulators.","volume":"18","author":"Levy","year":"2005","journal-title":"Am J Hypertens"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R55","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1096\/fj.03-0129com","article-title":"Differential regulation of in vivo angiogenesis by angiotensin II receptors.","volume":"17","author":"Walther","year":"2003","journal-title":"FASEB J"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens Res"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MED.0b013e3282f7026f","article-title":"The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.","volume":"15","author":"Perkins","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/CCO.0000000000000519","article-title":"The evolving role of diet in prostate cancer risk and progression.","volume":"31","author":"Kaiser","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.cej.0000199506.15571.37","article-title":"Angiotensin I-converting enzyme gene polymorphism modifies the smoking-cancer association: the Hisayama Study.","volume":"15","author":"Arima","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R60","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/clpt.1988.175","article-title":"Enhanced activation of the renin-angiotensin-aldosterone system in chronic cigarette smokers: a study of monozygotic twin pairs discordant for smoking.","volume":"44","author":"Laustiola","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R61","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer.","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R62","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R63","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejca.2015.02.004","article-title":"Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis.","volume":"51","author":"Pawitan","year":"2015","journal-title":"Eur J Cancer"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R64","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.canep.2020.101707","article-title":"Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population.","volume":"66","author":"W\u00e4ndell","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"key-10.7189\/jogh.14.04057-202403150922-R65","doi-asserted-by":"publisher","first-page":"e27547","DOI":"10.1371\/journal.pone.0027547","article-title":"Crosstalk between integrin alphavbeta3 and estrogen receptor-alpha is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2024\/jogh-14-04057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:34:02Z","timestamp":1710491642000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2024\/jogh-14-04057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":65,"URL":"https:\/\/doi.org\/10.7189\/jogh.14.04057","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"04057"}}